Back

Differentiation of Acute Disseminated Encephalomyelitis from Multiple Sclerosis Using a Novel Brain Lesion Segmentation and Classification Pipeline

Radi, O.; Huang, A.; Murakami, K.

2024-07-24 neuroscience
10.1101/2024.07.23.604829 bioRxiv
Show abstract

Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system, while Acute Disseminated Encephalomyelitis (ADEM) is a sudden, often monophasic inflammatory condition of the brain and spinal cord. Only 17% of ADEM cases are correctly diagnosed on the first visit due to overlapping clinical and radiological presentations with Multiple Sclerosis (MS) [1]. Both ADEM and MS are demyelinating diseases, meaning they cause brain lesions by damaging the myelin sheath, leading to scar tissue that disrupts nerve signals [2]. Previous machine learning pipelines have differentiated Neuromyelitis Optica Spectrum Disorder (NMOSD) (a different demyelinating disease) from MS and ADEM from NMOSD based on MRI imagery with varying accuracies [3, 4]. Our novel Classifier for Demyelinating Disease (CDD) pipeline is the first to differentiate ADEM from MS using MRI imagery. It does this in two stages: a segmentation stage which creates segmentation masks of the lesions and a classification stage to classify them as either ADEM or MS. Additionally, we introduce a novel ADEM dataset from open-access medical case reports. The CDD pipeline achieves an accuracy of 90.0% on our validation dataset, making it a potentially viable diagnostic tool in the future. All data and code is available here. 2

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.